Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone in THA
NCT02445898Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- Sep 2015
- Primary completion
- Jan 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone injection in orthostatic intolerance, sponsored by Rigshospitalet. Started Sep 2015; status: completed.
02
Drugs
methylprednisolone injection
03
Conditions
orthostatic intolerance
Beyond the preview
Go deeper on NCT02445898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02445898.